VY(5(Ts(((/(On((!n"En$75#"E}#d#$}%#&}'#)}* #+?+yKs7sO7ss7/s7N!} qMf1'1%n)jyyy&yEdyy !K Ey#()D()D<([)Dz()D()D()D6(U)D u(!*'S[$ #y%?$ &_y'~(&_'~** u*<'S*'SU)D"(#)D$*"*$(&)D'1((P'S&)D)n'S'S!'S(P2r34r57r8'9Gr:f;r<=r>@rA"BAyCAr1kc2&:f&3&<c=c@&A"D`yEF-CAjD`c74/M5N&5c9G6mM78M9:M< =)M>H?hM@AMBCTDM31/5NF/>?h0BFFQFF1G9>81U0!80!1!8227>:< >=)>H>AQHYHY`G9CH3NHNHNHNHNOIleONHNHOCH3CH3OOOSerLeuAsnPheOHValOONHNHNHNHNHOOOOThrIleNleNleCH3NHNHNHOOGlnNHONH2ArgOONHValValLeuONHOLeuOHOHOHAlaONHNHNHNHNH3AlaOHOHOValOOCH3ValOOAlaPheNHNHNHNHOOOOOHisChaOHOHValIleN      -  !"# $ % &''(())*+,-..//0011223344556677889:/;2<8=.>CD4@7A9B1?DEEFFGGHHIIJJKKLLMMNNOOPPQDRGSJ]BTBUTVTWVXXYYZX[Y\P^F_LaObQcI`cddeehcfeghiijhkjlMmQnjopqqrrssttuuvvwwxxyyzz{{||}}~~ppwqyz|}tsvb P` P` bXP` P`` X0` { h ` !!"` $p$h%X` x` #X#(#`O &r&pP'`t ))*c` **,` 8w`Pp` C6` 4` ` # `  ` h`Q =H` \`` ''(` %S%F%` (()D` p((` x(p` p(` 4((` p!!("8`  )W ` XK`  )W I`  ) rW e !`  )%h 0`  `  )h 0`` S @ ` )*((h) ` (:'`(x` )*( *` (:'`(0` **!*@` ' &'`  )"h" 0#` $($%` ##$c` 8(M`(PP*` % & '`  )'.W'! '` *i*!\*` * %*0 0*!p` **0*X` 'J&8'` **0*8` '&'` (:#'`#x($` *"c*!"V*"`0 *$*0$*& ` '%&%''` ))())*X` '&'` '!0&!H'"` '(&''(` |4y4P5 ` 7X78h` >X>? ` |AAPB` 1 0 1` ~2'2P3` }:: ;`` |3Z3M3` {` y??A(` x@@Ae` vE/ E"E` uFOFPG` tBBDH` sDDD` r667K` o557` n89:` mV666` j9{ 9: ` d@7 @8@` aVCCDH` _223R` \e44[5` Z?? ?` XeBvBi[C ` R8\8O8` Ke7=7Pp8` J::<(` Ie;;p<` H<<>` Ge=>p?p` FAAB` CFFGv` \87P;8JK\Figure 1. Chemical structures of the set of HIV-1 inhibitors selected for binding analysis.$H"$@MVT-101$7k#P7$>U758759((JG-365/..P/%ACETYLPEPSTATIN 6&6`A SKF107457        !" #!$"%#&$'()%&'()**++,,     -.-/.0/1021324354657687:9;:<;!>=?@A@#"B =<98BATSUT$%,VUWV-XWYXZY.[Z/\[01AB?&CD>ECFDGEHFIGJHKILJMKNLPRP(2SQ]R3'_`)a76a4^\QOc`db8higjh^]mkHOMNb_*5nl+ecdfe9:gfCkiDljomEFGpqnrosptqurvswtxuyvzw{x|y}z~{|<=?@;>}I~JKLMNOPQRSTUVX^W`YbZ[\]_ahgedfcGeneva9+ ;t-dg(+ 92'`XP x  (6(2++((